MAPT and Alzheimer disease: When plasma levels of p-Tau181 were plotted against t-Tau levels (Figure 3), we observed a concentration of p-Tau approximately equal to 15% of that of t-Tau, in agreement with a previous study [32], suggesting that the relative concentrations of p-Tau181 and t-Tau are similar in HCs and AD patients.